[PDF][PDF] Non-adherence to statins therapy and its impact on cardiac morbidity and mortality: A metanalysis
ZG Anebo, N Abacioglu - 2019 - academicjournals.org
Dyslipidemia is a major risk factor for cardiovascular disease, the leading cause of death
worldwide. Statins have been shown to significantly reduce morbidity and mortality in …
worldwide. Statins have been shown to significantly reduce morbidity and mortality in …
[PDF][PDF] Respite for hybrid coronary revascularization
Hybrid coronary revascularization incorporates a surgical anastomosis of the left internal
mammary artery to the left anterior descending coronary artery through a thoracotomy and …
mammary artery to the left anterior descending coronary artery through a thoracotomy and …
Management of dyslipidemia
PP Toth - … Cardiovascular Medicine in the Primary Care Setting, 2019 - Springer
Abstract In the United States, 790,000 people sustain a myocardial infarction annually or
one every 40 s (Mozaffarian et al. Circulation 131: e29–322, 2015). Of these, 114,000 will be …
one every 40 s (Mozaffarian et al. Circulation 131: e29–322, 2015). Of these, 114,000 will be …
Management of Hyperlipidaemia
N Raffoul - Australian Pharmacist, 2019 - search.informit.org
According to the 2011-12 Australian Health Survey, approximately 63% of Australian adults
have dyslipidaemia. One in three of these Australians have abnormally elevated low density …
have dyslipidaemia. One in three of these Australians have abnormally elevated low density …
Characteristics of Very Young Patients Who Experience a Myocardial Infarction: An Opportunity for Enhanced Prevention
Y Junjie - 2019 - search.proquest.com
Aims: We sought to compare the risk factor profiles and outcomes between very young
(age≤ 40) and young (40< age≤ 50) individuals who experienced a first-time MI at a young …
(age≤ 40) and young (40< age≤ 50) individuals who experienced a first-time MI at a young …
Potrošnja visokih doza statina kod pacijenata starijih od 65 godina u Republici Hrvatskoj 2015. godine
D Grgurević - 2019 - repozitorij.unizg.hr
Sažetak Cilj istraživanja:: Pacijenti stariji od 65 godina koji uzimaju visoke doze statina su
najosjetljivija populacija za nastanak i razvoj nuspojava. Ovim radom se odredio točan broj …
najosjetljivija populacija za nastanak i razvoj nuspojava. Ovim radom se odredio točan broj …
Statin intolerance and complementary medicines for cardiovascular disease
N Raffoul - Australian Pharmacist, 2019 - search.informit.org
Coronary heart disease is the single leading cause of death in Australia. Cardiovascular
disease (CVD) is responsible for almost a third of all deaths. Statins remain the cornerstone …
disease (CVD) is responsible for almost a third of all deaths. Statins remain the cornerstone …
Study of Young's Modulus and Failure Strength of Polyurethane-Based Binary Polymer Composite Structures Based on Stress-Strain Curve for Tissue Engineering …
The coronary arteries are of the important cardiovascular diseases. The autograft is the main
treatment for this problem, but in many patients, the autografts are not applicable. So, due to …
treatment for this problem, but in many patients, the autografts are not applicable. So, due to …
[PDF][PDF] Treat-To-Target Familial Hypercholesterolemia-Completion of a 10-12-years follow-up study on long-term effects of intensive lipid lowering treatment in FH …
AV Phung - 2019 - duo.uio.no
Background and aim: Familial hypercholesterolemia (FH) is a relatively common hereditary
disease characterized by severely elevated cholesterol levels since birth, resulting in a …
disease characterized by severely elevated cholesterol levels since birth, resulting in a …
Assessment of coronary artery calcium and its associations with familial and non-familial cardiovascular risk factors
CV Garcia - 2019 - research-repository.uwa.edu.au
The aim of this project was to evaluate the role of cardiac computed tomography scanning
for coronary artery calcium score in the assessment of subclinical coronary atherosclerosis …
for coronary artery calcium score in the assessment of subclinical coronary atherosclerosis …